The following management discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited interim consolidated financial statements and related notes which are included in Item 1 of this Quarterly Report on Form 10-Q, and with our audited financial statements included in our Form 10-K for the fiscal year ended June 30, 2021, filed with the Securities and Exchange Commission on October 13, 2021.





  20


  Table of Contents



This discussion and analysis provide information that management believes is relevant to an assessment and understanding of our results of operations and financial condition for the periods presented. The following selected financial information is derived from our historical consolidated financial statements and should be read in conjunction with such consolidated financial statements and notes thereto set forth elsewhere herein and the "Forward- Looking Statements" explanation included herein.





Our Business



Incorporation


We were incorporated in the state of Nevada on June 6, 1988.





Our Subsidiaries


Our wholly owned subsidiaries consist of the following

· United Project Development Corporation ("United Project"), incorporated in

Nevada on June 12, 2015.

· Vital Behavioral Health, Inc. ("Vital") incorporated in Nevada on October 1,

2020.

· iMetabolic Corp ("iMetabolic") incorporated in Nevada on July 1, 2013.

Vital's subsidiaries consist of:

· VBH Frankfort, LLC ("VBHF")

· VSL Frankfort LLC ("VSLF")






The Vital Acquisition


On February 16, 2021, we completed a Stock Exchange Agreement with Vital and each of its shareholders, providing for:

· Our acquisition of 100% of Vital's outstanding shares via our issuance of

16,840,000 shares to Vital in exchange for 100% of Vital's outstanding shares,

at which time Vital became our wholly-owned subsidiary.

· Our acquiring Vital's assets and assuming Vital's liabilities and its 2 wholly


   owned subsidiaries, VBHF and VSLF.



Pursuant to the Vital acquisition, we adopted our new business plan of providing inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues through facilities that we will operate.

On February 17, 2021, Vital formed the following 2 new Nevada incorporated entities, which became Vital's wholly owned subsidiaries:

· VBH Kentucky, Inc. ("VVHK")

· VBH Garden Grove, Inc. ("VBH Garden")

VBH Kentucky, Inc.

VBH Kentucky has succeeded to all of the preexisting and intended operations of VBH Frankfort (a wholly-owned predecessor entity of Vital), which substantially concluded all of its material operations as of May 3, 2021. VBH Kentucky will operate an outpatient substance abuse treatment facility in Frankfort, Kentucky, for which we have secured a lease as disclosed below. On August 26, 2021, we received a license to operate a non-hospital based alcohol and other drug treatment facility from the Kentucky Cabinet for Health and Family Services Office of the Inspector General.





  21


  Table of Contents




VSL Frankfurt, LLC

VSL Frankfort will offer sober-designated living quarters for individuals who are in recovery in conjunction with the Frankfort, Kentucky facility operated by VBH Kentucky. We anticipate hiring 4 full time and 3 part time employees at our Frankfurt facility, including a full time Clinical Director.

VBH Garden Grove, Inc.

VBH Garden intends to identify substance use disorder treatment facilities located in California to provide a West Coast patient solution that is able to economically accept select insurance payors that facilitate a broader national patient base for Vital. VBH Garden has identified various potential license holders and facilities located in Southern California and is in the due diligence phase for transaction consideration; however, there are no binding transactions for any licenses or facilities in California as of December 31, 2021 and there are no assurances that any such transaction will be completed in the future.





VBH Garden Grove



VBH Garden Grove intends to identify substance use disorder treatment facilities located in California to provide patient solutions that are able to economically accept select insurance payors to facilitate a broader patient base for Vital. VBH Garden Grove has identified various potential license holders and facilities located in Southern California and is in the due diligence phase for transaction consideration; however, there are no binding transactions for any licenses or facilities in California as of December 31, 2021.

Business of Vital Behavioral Health, Inc.

Vital's operational plans are contingent upon whether we are able to:

· Obtain sufficient debt or equity financing to operate U.S. substance abuse

facilities.

· Secure leases for the substance abuse facilities.

· Secure and have approved the required state licenses to operate the substance

abuse facilities.

· Meet applicable zoning requirements.

Upon our acquisition of Vital we became a health and wellness company with a focus in the drug and alcohol rehabilitation services industry. Vital intends to operate U.S. facilities focusing on substance abuse treatment and offer various programs that help provide a continuum of care to its patients. We intend to become a national operator of clinical and transitional housing services for clients affected by substance use disorders and co-occurring disorders. Our treatment plans will be based on an individualized approach and will be customized to meet each client's specific needs.

The facilities we intend to operate have access to Medically Monitored Withdrawal Management Services (MMWM), a Partial Hospitalization Program (PHP), an Intensive Outpatient Program (IOP), and an Outpatient Program (OP). Clients who participate in the PHP, IOP, and OP treatment programs will be eligible for housing through sober living accommodations that will be designed to give a client the ability to participate in his or her daily affairs and work and to have access to daily on-campus treatment at convenient times and locations.

We intend that most of our treatment facilities will be enrolled in Medicare or Medicaid and will bill and accept payments from those governmental programs. In most cases, it takes between 45 and 90 days for a Medicaid application to be processed and either accepted or denied by the state Medicaid office. However, depending on the circumstances and the state in which one resides, the application process could be shorter or longer. Most facilities that accept Medicaid generally provide programs with some degree of medical care and substance rehabilitation, including group and individual therapy, 12-step meetings, and other recovery activities, on a 24 hours per day basis in a highly structured setting. Short-term programs may last between 3 and 6 weeks and be followed by outpatient therapy. Long-term programs often last between 6 and 12 months and focus on re-socializing patients as they prepare to re-enter their communities. Intensive outpatient services (IOPs) typically offer at least 9 hours of therapy per week in sets of three 3-hour sessions, and some studies have found them to be similar to residential and inpatient programs in both services and effectiveness.





  22


  Table of Contents



Partial hospitalization programs (PHPs) provide care for people who need a more comprehensive level of treatment than standard or intensive outpatient. These programs typically consist of approximately 20 hours a week of treatment and may include vocational and educational counseling, family therapy, medically supervised use of medications, and treatment of co-occurring disorders. IOPs may also offer these services, but the time commitment of a PHP typically is greater.

We will offer both IOP and PHP services at our facilities and accept Medicare and Medicaid payor-qualified patients and clients.

VSL Frankfort intends to offer sober-designated living quarters for individuals who are in recovery. Operations for VSL Frankfort are intended to commence once VBH Kentucky obtains the operating entitlements for its outpatient substance use treatment facility in Frankfort, Kentucky. Until such time, VSL Frankfort's operations will be limited to planning and preparation.

All of our plans reflected above and below are contingent upon receiving adequate debt and/or equity financing of which there are no assurances we will be successful in obtaining.

Our Future Services and Solutions

We intend to provide quality, comprehensive, and compassionate care to adults struggling with alcohol and/or drug abuse and dependence as well as co-occurring mental health issues. We will maintain a research-based, disciplined treatment plan for all patients with schedules designed to engage the patient in an enriched recovery experience. Our purpose and passion are to empower the individual, their families, and the broader community through the promotion of optimal wellness of the mind, body, and spirit.

We plan to offer the following types of therapy: motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention. Our variety of therapy settings includes individual, group, and family therapies, recovery-oriented challenge therapies, expressive therapies (with a focus on music and art), and trauma therapies.

We also intend to provide Medicated-Assisted Treatment ("MAT"), which is the use of FDA-approved medications, in combination with counseling and behavioral therapies, to provide a "whole-patient" approach to the treatment of substance use disorders. We believe that it is particularly effective for treating certain conditions such as opioid use disorder, alcohol use disorder, and tobacco use disorder. The use of MAT has been shown to significantly reduce overdoses from opioids and to improve long-term abstinence.

Considering the high level of co-occurring substance abuse, mental health, and medical conditions, we will offer patients a spectrum of psychiatric, medical, and wellness-focused services based upon individual needs as assessed through comprehensive evaluations at admission and throughout participation in the program. To maximize the likelihood of long-term recovery, all program levels will provide patients access to the following services: assessment of individual substance abuse, mental health, medical history, and physical condition promptly upon admission; psychiatric evaluations; psychological evaluations, and services based on patient needs; follow-up appointments with physicians and psychiatrists; medication monitoring; educational classes regarding health risks, nutrition, smoking cessation, HIV awareness, life skills, healthy nutritional programs, and dietary plans; access to fitness facilities; interactive wellness activities; and structured daily schedules designed for restorative sleep patterns.

We plan to emphasize clinical treatment, as well as the therapeutic value of overall physical and nutritional wellness. We are committed to providing fresh and nutritious meals throughout a patient's stay in order to promote healthy routines, beginning with diet and exercise. Our facilities will offer comprehensive work-out facilities either on-site or within walking distance, as well as various exercise classes and other amenities. We will support long-term recovery for patients through research-based methodologies and individualized treatment planning while utilizing 12-step programs, which are a set of guiding principles outlining a course of action for recovery.





  23


  Table of Contents



We plan to have a differentiated ability to manage dual diagnosis cases and coordinate treatment of individuals suffering from the common combination of mental illness and substance abuse simultaneously. These patients participate in education and discussion-oriented groups designed to provide information regarding the psychiatric disorders that co-occur with chemical dependency.

We plan to have a strong emphasis on tracking patient satisfaction scores in order to measure our patient and staff interaction and overall outcome and reputation. In addition to patient satisfaction surveys that we will receive after a patient's discharge, we also will solicit feedback during a patient's stay at our inpatient facilities. This allows us to further tailor an individual's treatment plan to emphasize the programs that have been more impactful to a particular patient.

We believe in tracking clinical outcomes. We intend to track and measure patient outcomes in order to drive continual improvement in our programs.

We plan offer a full spectrum of treatment services to patients based upon individual needs that are assessed through comprehensive evaluations at admission and throughout their participation in the program. The assignment and frequency of services will correspond to individualized treatment plans within the context of the level of care and treatment intensity level.

· Detoxification ("detox"). Detoxification is usually conducted at an inpatient


   facility for patients with physical or psychological dependence. Detoxification
   services are designed to clear toxins out of the body so that the body can
   safely adjust and heal itself after being dependent upon a substance. Patients
   are medically monitored 24 hours per day, seven days per week, by experienced
   medical professionals who work to alleviate withdrawal symptoms through
   medication, as appropriate. We plan to provide detoxification services for
   several substances including alcohol, sedatives, and opiates.



· Residential Treatment. Residential care is a structured treatment approach


   designed to prepare patients to return to the general community with a sober
   lifestyle, increased functionality, and improved overall wellness. Treatment is
   provided on a 24 hours per day, seven days per week basis, and services
   generally include a minimum of two individual therapy sessions per week,
   regular group therapy, family therapy, didactic and psycho-educational groups,
   exercise (if cleared by medical staff), case management, and recreational
   activities. Medical and psychiatric care will be available to all patients, as
   needed, through our planned contracted professional physician groups.



· Partial Hospitalization. Partial hospitalization is a structured program


   providing care a minimum of 20 hours per week. This program is designed for
   patients who are stable enough physically and psychologically to participate in
   everyday activities but who still require a degree of medical monitoring.
   Services include a minimum of weekly individual therapy, regular group therapy,
   family education and family therapy, didactic and psycho-educational groups,
   exercise (if cleared by medical staff), case management, and off-site recovery
   meetings and activities. Medical and psychiatric care will be available to all
   patients, as needed, through our planned contracted professional physician
   groups.



· Intensive Outpatient Services. Less intensive than the aforementioned levels of


   care, intensive outpatient services are comprised of a structured program
   providing care three days per week for three hours per day at a minimum.
   Designed as a "step down" from partial hospitalization, this program reinforces
   progress and assists in the attainment of sobriety, reduction of detrimental
   behaviors, and improved overall wellness of patients while they integrate and
   interact in the community. Services include weekly individual therapy, group
   therapy, family education and family therapy, didactic and psycho-educational
   groups, case management, off-site recovery meetings and activities, and
   intensive transitional and aftercare planning.



· Outpatient Services. Traditional outpatient services are delivered in regularly

scheduled sessions, usually less the nine hours per week. Outpatient services

include professionally directed screening, assessment, therapy, and other

services designed to support successful transition to the community and

long-term recovery. These services are tailored to a person's specific needs

and stage of recovery and may involve many modalities, including motivational

enhancement, family therapy, educational groups, occupational and recreational

therapy, psychotherapy, and pharmacotherapy.






  24


  Table of Contents



· Ancillary Services. In addition to our inpatient and outpatient treatment


   services, we intend to provide medical monitoring for adherence to addiction
   treatment, clinical diagnostic laboratory services, and physician services to
   our patients through our contracted laboratories and professional physician
   groups. We believe toxicological monitoring of patients is an important
   component of substance abuse treatment. Patients are evaluated for illicit
   substances upon admission and thereafter on a random basis and as otherwise
   determined to be medically necessary by the treating physician.



· Sober Living Facilities. We plan to provide sober living arrangements that


   serve as an interim environment for patients transitioning from inpatient
   treatment centers to lower levels of care and eventually back to their former
   living arrangements. Sober living facilities enable us to utilize existing beds
   for patients requiring higher levels of care, while still providing housing for
   patients completing outpatient treatment programs. We provide sober living
   arrangements to patients through our owned and leased properties in Texas,
   Nevada, Mississippi, and Florida. We plan to continue using sober living
   facilities as a complement to our outpatient services.




Business Strategies



Vital plans to hire highly trained and experienced clinical staff to deploy research-based treatment programs with structured curricula for detoxification, inpatient treatment, partial hospitalization, and intensive outpatient care. By keeping the majority of its treatment facilities and housing on campuses that are conveniently located within walking distance to traditional community services, we are striving to create so-called 'sober cities' in the United States that will nurture its clients' development at all stages from detox to long-term self-sufficiency. By applying a tailored treatment program based on the individual needs of each patient, many of whom require treatment for a co-occurring mental health disorder such as depression, bipolar disorder, or schizophrenia, we believe we will offer the level of quality care and service necessary for our patients to achieve and maintain sobriety. Development of our business and the Vital Behavioral Health and Vital Sober Living national brands is contingent upon our ability to raise sufficient funds to fund hiring clinical experts, leasing facilities, and hiring professional staff, and national sales and marketing programs. We will engage the following strategies:

· Clinical excellence and outcomes-driven treatment.Our operations require us to


   comply with the national standard for quality and sustainable outcomes in
   addiction treatment and to ongoing measurement and transparency regarding
   patient outcomes. In addition to measurement of patient outcomes and
   satisfaction with treatment, we plan to advance utilization of modern,
   evidence-based interventions that address addiction as a chronic brain disease,
   as supported by the science.



· Improve census over time at existing facilities.We plan to connect with


   potential patients through a multi-faceted program that involves education
   about the disease of addiction and the development of relationships with
   healthcare professionals, digital marketing, as well as such traditional
   channels as television, radio and print advertising. We plan to will take a
   consultative, empathetic approach in operating our admissions department to
   allow our personnel to effectively identify and enroll patients who may benefit
   from our treatment service offerings.



· Target complementary growth opportunities.We plan to pursue growth


   opportunities that are complementary to our business, including providing
   laboratory services to other substance abuse treatment providers and expanding
   other ancillary services.



· Develop outpatient operations. We plan to selectively pursue opportunities to

add outpatient centers to complement our broader network of inpatient treatment

facilities. We believe expanding our reach by developing or acquiring premium

outpatient facilities of a quality consistent with our inpatient services will

further enhance our brand and our ability to provide a more comprehensive suite

of services across the spectrum of care.






  25


  Table of Contents



· Opportunistically diversify our portfolio of treatment facilities. We intend to


   selectively seek acquisition opportunities to expand and diversify our
   geographic presence, service offerings, and the portion of the population that
   can access our services based on their individual healthcare coverage We
   believe that most mental health and substance abuse treatment companies in
   operation are small, regional operations and this high level of fragmentation
   presents us with the opportunity to acquire facilities or small providers and
   create economies of scale and enhanced patient care. All of the above plans are
   contingent upon adequate funding of which there are no assurances.




Sales and Marketing



We intend to use a multi-faceted approach to reach potential patients suffering from the disease of addiction and co-occurring psychiatric disorders. This multi-pronged approach will include:

· National Marketing Force. We intend to deploy and manage a team of


   representatives that will focus on developing relationships with hospitals,
   other treatment facilities, psychiatrists, therapists, social workers,
   employers, unions, alumni, and employee assistance programs. Our sales
   representatives will educate these various constituents about the disease of
   addiction and the variety of treatment services that we provide.



· Multi-Media Marketing. Through comprehensive online directories of treatment


   providers, treatment provider reviews, user content that discusses the disease
   of addiction, treatment and recovery, as well as discussion forums and
   professional communities, our future addiction-related websites will serve
   families and individuals who are struggling with addiction and seeking
   treatment options. Additionally, we plan to pursue advertising opportunities in
   television commercials, radio spots, newspaper articles, medical journals, and
   other print media that promote our facilities and have the intent to build our
   integrated, national brand.



· Recommendations by Alumni. We anticipate receiving new patients who are


   directly referred to our facilities by our satisfied and supportive alumni, as
   well as their friends and families. As our national brand continues to grow and
   our business continues to increase, we believe our alumni will become an
   increasingly important source of business for us.



The extent that we are able to implement the foregoing or even able to implement any of the foregoing sales and marketing plans are contingent upon adequate funding, of which there are no assurances.





Admissions Center Operations


We intend to maintain a 24-hours per day, seven days per week, remote admissions center. Our centralized admissions center initially will be provided by a third-party provider that will focus on outreach and enrolling patients. As part of its role, the admissions center team will conduct benefits verification, handle initial communication with insurance companies, complete patient intake screenings, consult with our clinicians where necessary regarding a potential patient's specific medical or psychological condition, begin the pre-certification process for treatment authorization, help each patient choose a proper treatment facility for his or her clinical and financial needs, and assist patients with arrangements and logistics.





Professional Groups


We plan to become affiliated with groups of physicians and mid-level service providers that may provide certain professional services to our patients through professional services agreements with certain of our treatment facilities (the "Professional Groups"). Under the professional services agreements, the Professional Groups may provide a physician to serve as medical director for the applicable facility. The Professional Groups may either bill the payor for their services directly or be compensated by the treatment facility based on fair market value hourly rates.





  26


  Table of Contents




Revenues


We plan to generate revenues through our Vital Behavioral Health operations from behavioral health treatment services at our inpatient and outpatient treatment facilities, which will be derived from personally funded patients (i.e., private payor), insurance companies (e.g., United Healthcare and Blue Cross and Blue Shield), and government program payors (e.g., Medicaid and Medicare) that act as the primary payment or reimbursement source of funds for our patient services. We also plan to generate revenues through our Vital Sober Living operations as a landlord through the provision of sober living residences that are supported by our Vital Behavioral Health patient services. Initially, we expect that our revenue-producing operations will commence in Frankfort, Kentucky.







RESULTS OF OPERATIONS


Results of Operations for the Three Months Ended December 31, 2021, and 2020.





Below is a summary of the results of operations for the three months ended
December 31, 2021, and 2020.



                                                  For the Three Months Ended December 31,
                                              2021          2020         $ Change      % Change
Revenue:
Net revenue                                $        -     $       -     $        -          0.00 %

Operating expenses
Professional fees                              69,028        21,570         47,458        220.02 %
General and administrative                    268,547         2,712        265,835       9802.18 %
Total operating costs and expenses            337,575        24,282        313,293       1290.23 %
 Operating loss                              (337,575 )     (24,282 )     (313,293 )     1290.23 %

Interest expense, net                         (50,246 )      (3,990 )      (46,256 )     1159.30 %
Gain on change in fair value of
derivative liability                          238,397             -        238,397          0.00 %
Other income (expense), net                         -       (23,402 )       23,402       -100.00 %
Net loss, before income taxes                (149,424 )     (51,674 )      (97,750 )     -189.17 %
Benefit from income taxes                           -        10,852        (10,852 )     -100.00 %
Loss from continuing operations              (149,424 )     (40,822 )     (108,602 )      266.04 %

Discontinued operations:
Gain on sale of discontinued operations,
net of tax                                          -       240,312       (240,312 )     -100.00 %
Income from discontinued operations, net
of tax                                              -       240,312       (240,312 )     -100.00 %
Net income (loss)                          $ (149,424 )   $ 199,490     $ (348,914 )     -174.90 %
Less: net loss attributable to
non-controlling interest                       (6,056 )           -         (6,056 )        0.00 %
Net income (loss) attributable to UPD
Holding Corp.                              $ (143,368 )   $ 199,490     $ (342,858 )     -171.87 %




  27


  Table of Contents




Revenue and Cost of Revenue


We generated no revenue for the three months ended December 31, 2021, and December 30, 2020.





Professional Fees



We incurred professional fees of $69,028 and $21,570 for the three months ended December 31, 2021, and December 31, 2020, respectively. Our professional fees increased by $47,458 for the three months ended December 31, 2021, compared to the same period in 2020. The increase is primarily attributable to accounting and legal fees.

As funding permits, we expect to incur higher professional fees associated with on-going development of our brand, customers, and other relationship development.

General and Administrative Expenses

For the three months ended December 31, 2021, and December 31, 2020, we incurred general and administrative expenses of $268,547 and $2,712, respectively, representing an increase of $265,835 for the three months ended December 31, 2021, compared to the same period in 2020. The $265,835 increase in general and administrative expenses is primarily attributable to our acquisition of VBH, Vital, and VSL consisting of the following: rent expense and related facilities costs totaling approximately $93,675; approximately $81,400 in payroll expenses; approximately $11,266 in insurance expense and approximately $71,191 in consulting fees, none of which were incurred during the three months ended December 31, 2020.

We expect our expenses to increase over the next several periods should we be successful in our new business plan, which will primarily consist of facilities costs, management and other salaries, travel, and other corporate overhead.





Interest Expense


Interest expense was $50,246 and $3,990 for the three months ended December 31, 2021, and December 31, 2020, respectively, representing an increase of $46,256. The increase is primarily the result of the incurrence of new debt obligations totaling $544,000.

Change in Fair Value of Derivative Liabilities

As of December 31, 2021, the Company did not have enough authorized and unissued shares of common stock to settle all its convertible debt obligations. As a result, the Company recognized obligations to issue a total of 4,456,907 shares of common stock upon convertible debt conversion to derivative liabilities in the accompanying consolidated balance sheets. The value of the derivative liability moves in parallel with the movement of the market value of the shares of the Company. Due to the decline in share price from $0.0999 per share in September 30, 2021 to $0.300 in December 31, 2021, the value of the derivative liability has decreased significantly. For the three months ended December 31, 2021, the Company recognized a gain on the change in the fair value of derivative liabilities of $238,397. The Company had derivative liability obligations of $276,906 as of September 30, 2021 compared to $38,509 as of December 31, 2021.





Discontinued Operations



On December 31, 2020, we completed the disposition of our prior Record Street Brewing Operations. The primary consideration in the disposal was the purchaser's assumption of liabilities totaling approximately $251,000. As a result of the assets acquired not having any book value, we recognized a gain on disposal of approximately $240,000, net of tax of approximately $11,000.





  28


  Table of Contents



Results of Operations for the Six Months Ended December 31, 2021, and 2020.





Below is a summary of the results of operations for the six months ended
December 31, 2021, and 2020.



                                                   For the Six Months Ended December 31,
                                              2021           2020         $ Change      % Change
Revenue:
Net revenue                                $        -     $        -     $        -          0.00 %

Operating expenses
Professional fees                             126,845         67,186         59,659         88.80 %
General and administrative                    508,708          5,192        503,516       9697.92 %
Total operating costs and expenses            635,553         72,378        563,175        778.10 %
 Operating loss                              (635,553 )      (72,378 )     (563,175 )      778.10 %

Interest expense, net                         (77,905 )       (9,849 )      (68,056 )      690.99 %
Gain on change in fair value of
derivative liability                          199,454              -        199,454          0.00 %
Other income (expense), net                         -        (23,402 )       23,402       -100.00 %
Net loss, before income taxes                (514,004 )     (105,629 )     (408,375 )     -386.61 %
Benefit from income taxes                           -         10,852        (10,852 )     -100.00 %
Loss from continuing operations              (514,004 )      (94,777 )     (419,227 )      442.33 %

Discontinued operations:
Gain on sale of discontinued operations,
net of tax                                          -        240,312       (240,312 )     -100.00 %
Income from discontinued operations, net
of tax                                              -        240,312       (240,312 )     -100.00 %
Net income (loss)                          $ (514,004 )   $  145,535     $ (659,539 )     -453.18 %
Less: net loss attributable to
non-controlling interest                      (10,822 )            -        (10,822 )        0.00 %
Net income (loss) attributable to UPD
Holding Corp.                              $ (503,182 )   $  145,535     $ (648,717 )     -445.75 %




Revenue and Cost of Revenue


We generated no revenue for the three months ended December 31, 2021, and December 30, 2020.





Professional Fees



We incurred professional fees of $126,845 and $67,186 for the six months ended December 31, 2021, and December 31, 2020, respectively. Our professional fees increased by $59,659 for the six months ended December 31, 2021, compared to the same period in 2020. The increase is primarily attributable to accounting and legal fees.

As funding permits, we expect to incur higher professional fees associated with on-going development of our brand, customers, and other relationship development.

General and Administrative Expenses

For the six months ended December 31, 2021, and December 31, 2020, we incurred general and administrative expenses of $508,708 and $5,192, respectively, representing an increase of $503,516 for the six months ended December 31, 2021, compared to the same period in 2020. The $503,516 increase in general and administrative expenses is primarily attributable to our acquisition of VBH, Vital, and VSL consisting of the following: rent expense and related facilities costs totaling approximately $163,259; approximately $133,186 in payroll expenses; approximately $22,634 in insurance expense and approximately $157,781 in consulting fees, none of which were incurred during the six months ended December 31, 2020.

We expect our expenses to increase over the next several periods should we be successful in our new business plan, which will primarily consist of facilities costs, management and other salaries, travel, and other corporate overhead.





  29


  Table of Contents




Interest Expense


Interest expense was $77,905 and $9,849 for the six months ended December 31, 2021, and December 31, 2020, respectively, representing an increase of $68,056. The increase is primarily the result of the incurrence of new debt obligations totaling $544,000.

Change in Fair Value of Derivative Liabilities

As of December 31, 2021, the Company did not have enough authorized and unissued shares of common stock to settle all its convertible debt obligations. As a result, the Company recognized obligations to issue a total of 4,456,907 shares of common stock upon convertible debt conversion to derivative liabilities in the accompanying consolidated balance sheets. The value of the derivative liability moves in parallel with the movement of the market value of the shares of the Company. Due to the decline in share price from $0.1009 per share in June 30, 2021 to $0.300 in December 31, 2021, the value of the derivative liability has decreased significantly. For the six months ended December 31, 2021, the Company recognized a gain on the change in the fair value of derivative liabilities of $199,454. The Company had derivative liability obligations of $237,963 as of June 30, 2021 compared to $38,509 as of December 31, 2021.





Discontinued Operations


On December 31, 2020, we completed the disposition of our prior Record Street Brewing Operations. The primary consideration in the disposal was the purchaser's assumption of liabilities totaling approximately $251,000. As a result of the assets acquired not having any book value, we recognized a gain on disposal of approximately $240,000, net of tax of approximately $11,000.

Liquidity and Capital Resources

As of December 31, 2021, we had a working capital deficit of approximately $1,138,168. Over the next twelve months, we have estimated that in order to maintain reporting company status as defined under the Securities Exchange Act of 1934, we will require cash for general and administrative expenses primarily consisting of facilities costs payroll expenses and professional fees, which include accounting, legal and other professional fees, as well as filing fees.

We believe we will be able to meet these costs by raising additional funds through various financing sources, including the sale of our common or preferred stock and the procurement of commercial debt financing, and through our operations which are expected to commence during the second quarter of fiscal 2022. However, no assurance can be given that we will be able to raise additional capital, when needed or at all, or that such capital, if available, will be on acceptable terms. Further, we have recently entered the rehabilitation services industry and may not be able to operate our facilities at levels sufficient to meet our on-going obligations.

For the six months ended December 31, 2021, our operational cash flows primarily consisted of incurring expenses in the normal course of business at levels commensurate with its funding levels and resulting inabilities to commence commercially viable operations. Net cash used in operating activities was $598,084 during the six months ended December 31, 2021 and consisted of a net loss of $514,004 and net change in operating assets and liabilities of $49,451, which was offset by non-cash items of $133,531. The primary non-cash items for the six months ended December 31, 2021, consisted of amortization of debt discount of $23,367 and non-cash warrant amortization of $22,000 offset by change in derivative liabilities of $199,454. The significant change in operating assets and liabilities was a gain in the fair value of derivative liabilities. We expect these operational cash uses to increase as we begin our operations in the first half of fiscal 2022.

Our investing activities consisted of acquiring property and equipment totaling approximately $57,615. We expect to make additional capital expenditures as our rehabilitation facilities increase operations.

During the six months ended December 31, 2021, we generated $786,743 of net cash from financing activities through the issuance of convertible debt and notes payable of $558,000 and proceeds from sale of non-controlling interest of $250,000, which was offset by a $21,257 payments on notes payable and accrued interest. We expect to continue our financing efforts throughout fiscal 2022.





  30


  Table of Contents



Off-Balance Sheet Arrangements

During the six months ended December 31, 2021, and the year ended June 30, 2020, we did not engage in any off-balance sheet arrangements as set forth in Item 303(a)(4) of the Regulation S-K.





Critical Accounting Policies




The discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with US GAAP. The preparation of these financial statements requires our management to make significant estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These items are monitored and analyzed by our management for changes in facts and circumstances, and material changes in these estimates could occur in the future.





Business Combinations


Business combinations are accounted for at fair value. Acquisition costs are expensed as incurred and recorded in general and administrative expenses; previously held equity interests are valued at fair value upon the acquisition of a controlling interest; restructuring costs associated with a business combination are expensed subsequent to the acquisition date; and changes in deferred tax asset valuation allowances and income tax uncertainties after the acquisition date affect income tax expense. Measurement period adjustments are made in the period in which the amounts are determined, and the current period income effect of such adjustments will be calculated as if the adjustments had been completed as of the acquisition date. All changes that do not qualify as measurement period adjustments are also included in current period earnings. The accounting for business combinations requires estimates and judgment as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management's estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of goodwill or the recognition of additional consideration which would be expensed. The fair value of contingent consideration is re-measured each period based on relevant information and changes to the fair value are included in the operating results for the period.

Goodwill

Goodwill represents the excess of fair value over identifiable tangible and intangible net assets acquired in business combinations. Goodwill is not amortized, instead goodwill is reviewed for impairment at least annually, or on an interim basis between annual tests when events or circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value.

Embedded Conversion Features and Other Equity-linked Instruments (Derivative Liabilities)

The Company classifies all of its embedded debt conversion features, and other derivative financial instruments as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) contracts that contain reset provisions. The Company assesses classification of its equity-linked instruments at each reporting date to determine whether a change in classification between equity and liabilities (assets) is required. As of December 31, 2021, the Company did not have enough authorized and unissued shares to settle all outstanding equity-linked instruments resulting in the reclassification of certain instruments to liability. The Company reclassifies outstanding instruments based on allocating the unissued shares to contracts with the earliest inception date resulting in the contracts with the latest inception date being recognized as liabilities first.





  31


  Table of Contents



The Company accounts for contracts convertible into common stock in excess of its authorized capital as derivative as liabilities. The derivative liabilities are re-measured at fair value with the changes in the value reported as a component of other income (expense) in the accompanying consolidated results of operations. The derivative liabilities are measured at fair value using a Black Scholes option pricing model. The model is based on assumptions including quoted market prices and estimated volatility factors based on historical quoted market prices for the Company's common stock and are classified within Level 3 of the fair value hierarchy as established by US GAAP. As of December 31, 2021, all derivative liability contracts are convertible into a fixed number of shares of common stock.

© Edgar Online, source Glimpses